Prostacyclin

Prostacyclin is a powerful, short-acting vasodilator that plays a pivotal role in the maintenance of vascular homeostasis. It is a naturally occurring bioactive lipid that is produced mainly by the endothelial cells of blood vessels. Prostacyclin is known to have anti-inflammatory and anti-thrombotic activities, and it has been found to be involved in the regulation of vascular tone, cell proliferation and cell migration. It also influences microcirculatory perfusion and platelet aggregation, making it a vital pathway in preventing cardiovascular disease. Prostacyclin has many clinical applications, from treating pulmonary hypertension to prevention of restenosis after angioplasty. In addition, prostacyclin has been studied as a potential agent in treating diseases associated with abnormal blood vessel remodeling, such as rheumatoid arthritis.

← Journal of Drug Resistant Pathogen Research

Related Articles

1 journal(s) found

Drug Resistant Pathogen Research

ISSN: Coming Soon
Type: Open Access Journal
Editor-in-Chief: Godfred Menezes, Associate Professor- Medical Microbiology & Immunology (MMI) Clinical Microbiologist (MOH D58119) RAK College of Medical Sciences (RAKCOMS) RAK Medical & Health Sciences University (RAKMHSU)
Pathogen is anything that can produce disease. Typically the term is used to describe an infectious agent such as a virus, bacterium, prion, a fungus, or even another micro-organism. There are several substrates including pathways where the pathogens can invade a host. Diseases caused by organisms in humans are known as pathogenic diseases.